Showing results (171-180 of 198) with videos related to

Sort By:
Pageof 20
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2010
Randomized Trial of prophylactic granulocyte colony-stimulating factor during rapid COJEC induction in pediatric patients with high-risk neuroblastoma: the European HR-NBL1/SIOPEN studyRuth Ladenstein, Dominique Valteau-Couanet, Penelope Brock, et al.
Frontiers in Oncology|September 26, 2024
Heterogeneous SSTR2 target expression and a novel KIAA1549::BRAF fusion clone in a progressive metastatic lesion following 177Lutetium-DOTATATE molecular radiotherapy in neuroblastoma: a case reportSe Whee Sammy Park, Susanne Fransson, Fredrik Sundquist, et al.
Pediatric Blood & Cancer|July 18, 2018
Risk stratification of high-risk metastatic neuroblastoma: A report from the HR-NBL-1/SIOPEN studyDaniel A Morgenstern, Ulrike Pötschger, Lucas Moreno, et al.
Cancer Research Communications|March 6, 2023
MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: MAX Interaction and Tumor Growth in a MYC-Dependent MannerAlina Castell, Qinzi Yan, Karin Fawkner, et al.
Autophagy|March 20, 2025
Kit-mediated autophagy suppression driven by a viral oncoprotein emerges as a crucial survival mechanism in Merkel cell carcinomaHao Shi, Yajie Yang, Jiwei Gao, et al.
American Journal of Medical Genetics. Part A|July 11, 2024
Occurrence of cancer in Marfan syndrome: Report of two patients with neuroblastoma and review of the literatureCarolina Maya-González, Angelica Maria Delgado-Vega, Fulya Taylan, et al.
Journal of Translational Medicine|May 24, 2023
The Swedish childhood tumor biobank: systematic collection and molecular characterization of all pediatric CNS and other solid tumors in SwedenTeresita Díaz de Ståhl, Alia Shamikh, Markus Mayrhofer, et al.
Scientific Reports|July 20, 2022
Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroupAngela Martinez-Monleon, Hanna Kryh Öberg, Jennie Gaarder, et al.
Cancer Cell|December 18, 2014
The risk-associated long noncoding RNA NBAT-1 controls neuroblastoma progression by regulating cell proliferation and neuronal differentiationGaurav Kumar Pandey, Sanhita Mitra, Santhilal Subhash, et al.
Cell Reports|September 23, 2020
11q Deletion or ALK Activity Curbs DLG2 Expression to Maintain an Undifferentiated State in NeuroblastomaJoachim Tetteh Siaw, Niloufar Javanmardi, Jimmy Van den Eynden, et al.
Pageof 20